Spiriva and Small cell lung cancer - from FDA reports


Summary

Small cell lung cancer is found among people who take Spiriva, especially for people who are female, 60+ old , have been taking the drug for < 1 month, also take medication Symbicort, and have Chronic obstructive pulmonary disease. This review analyzes which people have Small cell lung cancer with Spiriva. It is created by eHealthMe based on reports of 97,353 people who have side effects when taking Spiriva from FDA, and is updated regularly.

What to expect?

If you take Spiriva and have Small cell lung cancer, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Spiriva and have Small cell lung cancer

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On May, 18, 2017

97,353 people reported to have side effects when taking Spiriva.
Among them, 34 people (0.03%) have Small Cell Lung Cancer


Number of reports submitted per year:

Could Spiriva cause Small cell lung cancer?

Time on Spiriva when people have Small Cell Lung Cancer *:

  • < 1 month: 42.86 %
  • 1 - 6 months: 14.29 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 28.57 %
  • 2 - 5 years: 14.29 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Small Cell Lung Cancer when taking Spiriva *:

  • female: 64.71 %
  • male: 35.29 %

Age of people who have Small Cell Lung Cancer when taking Spiriva *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 4.35 %
  • 60+: 95.65 %

Top conditions involved for these people *:

  • Chronic Obstructive Pulmonary Disease (29 people, 85.29%)
  • High Blood Pressure (8 people, 23.53%)
  • High Blood Cholesterol (4 people, 11.76%)
  • Hypothyroidism (3 people, 8.82%)
  • Gastroesophageal Reflux Disease (2 people, 5.88%)

Top co-used drugs for these people *:

  • Symbicort (6 people, 17.65%)
  • Combivent (4 people, 11.76%)
  • Lasix (3 people, 8.82%)
  • Amlodipine (3 people, 8.82%)
  • Advair Hfa (3 people, 8.82%)

Top other side effects for these people *:

  • Breathing Difficulty (7 people, 20.59%)
  • Pneumonia (6 people, 17.65%)
  • Lung Neoplasm Malignant (4 people, 11.76%)
  • Lower Respiratory Tract Infection (3 people, 8.82%)
  • Joint Pain (3 people, 8.82%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Small cell lung cancer when taking Spiriva?

Spiriva

Spiriva has active ingredients of tiotropium bromide monohydrate. It is often used in chronic obstructive pulmonary disease. (latest outcomes from Spiriva 98,422 users)

Small Cell Lung Cancer

Small cell lung cancer (small cell cancer tumour of lung) has been reported by people with rheumatoid arthritis, chronic obstructive pulmonary disease, high blood pressure, multiple sclerosis, lung cancer - small cell (latest reports from 1,501 Small cell lung cancer patients).

Browse all side effects of Spiriva

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Small cell lung cancer

Small cell lung cancer

Could your condition cause Small cell lung cancer

Small cell lung cancer

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Spiriva and have Small cell lung cancer.

Can you answer these questions?

More questions for: Spiriva, Small cell lung cancer

You may be interested in these reviews

More reviews for: Spiriva, Small cell lung cancer